Comparative Risk and Policy Analysis in Environmental Health

Risk Analysis

Volumn 23, Issue 6, 2003, Pages 1337-1349

  Wong, E Y ^a   Ponce, R A ^a   Farrow, S ^b   Bartell, S M ^c   Lee, R C ^d   Faustman, E M ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

Aggregate risk; Air pollution; Comparative risk; Cumulative risk; Fish consumption

Indexed keywords

HARMFUL EXPOSURE; POLICY ANALYSIS;

AIR POLLUTION; COST BENEFIT ANALYSIS; COST EFFECTIVENESS; ENVIRONMENTAL IMPACT; ENVIRONMENTAL PROTECTION; HEALTH CARE; HEALTH RISKS; TUMORS;

RISK ASSESSMENT;

ANALYTICAL METHOD; POLLUTION EXPOSURE; PUBLIC HEALTH; RISK ASSESSMENT;

AIR POLLUTION; CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ENVIRONMENTAL HEALTH; FISH; FOOD INTAKE; HEALTH CARE POLICY; HEALTH HAZARD; PERFORMANCE; PUBLIC HEALTH; QUANTITATIVE ANALYSIS; RISK ASSESSMENT;

AIR POLLUTION; ANIMALS; COST-BENEFIT ANALYSIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; FISHES; FOOD CONTAMINATION; HUMANS; POLICY MAKING; PUBLIC POLICY; RISK ASSESSMENT; UNITED STATES;

EID: 0347052824     PISSN: 02724332     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0272-4332.2003.00405.x     Document Type: Conference Paper

References (48)

1. U.S. EPA. (2001). Framework for Cumulative Risk Assessment Draft (NCEA-F-1098). Washington, DC: Office of Research and Development, U.S. EPA.
2. NRC. (1994). Ranking Hazardous-Waste Sites for Remedial Action. Washington, DC: National Academy Press.
3. PCRARM. (1997). Framework for Environmental Health Risk Management. Final Report, Volume 1. Washington, DC: Presidential/Congressional Commission on Risk Assessment and Risk Management.
4. ILSI. (1999). A Framework for Cumulative Risk Assessment. Washington, DC: ILSI Press.
5. Bogdanffy, M. S., Daston, G., Faustman, E. M., Kimmel, C. A., Kimmel, G. L., Seed, J., & Vu, V. (2001). Harmonization of cancer and noncancer risk assessment: Proceedings. of a consensus-building workshop. Toxicological Sciences, 61(1), 18-31.
6. Curtis, S. B., Bartell, S., Faustman, E. M., & Griffith, W. (In preparation). An index of harm for exposure to a combination of radiation and chemical pollutants.
7. U.S. EPA. (2000). Proposed Guidance on Cumulative Risk Assessment of Pesticide Chemicals that Have a Common Mechanism of Toxicity, Public Comment Draft. Washington, DC: Office of Pesticide Programs, US EPA.
8. National Research Council. (1983). Risk Assessment in the Federal Government: Managing the Process. Washington, DC: National Academy Press.
9. U.S. EPA. (1991). Guidelines for developmental toxicity risk assessment. Federal Register, 56, 63798-63826.
10. Dourson, M. L., & DeRosa, C. T. (1991). The use of uncertainty factors in establishing safe levels of exposure. In D. Krewski & C. Franklin (Eds.), Statistics in Toxicology (pp. 613-627). New York: Gordon and Breach.
11. Dourson, M. L., & Stara, J. F. (1983). Regulatory history and experimental support of uncertainty (safety) factors. Regulatory Toxicology and Pharmacology, 3(3), 224-238.
12. Kimmel, C. A. (1990). Quantitative approaches for human risk assessment for noncancer health effects. Neurotoxicology, 11, 189-198.
13. Faustman, E. M., & Bartell, S. M. (1997). Review of noncancer risk assessment: Application of benchmark dose methods. Human and Ecological Risk Assessment, 3(5), 893-920.
14. Crump, K. S. (1984). A new method for determining allowable daily intakes. Fundamentals of Applied Toxicology, 4, 854-871.
15. Allen, B. C., Kavlock, R. J., Kimmel, C. A., & Faustman, E. M. (1994). Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels. Fundamental and Applied Toxicology, 23(4), 487-495.
16. U.S. EPA. (1986). Guidelines for carcinogen risk assessment. Federal Register, 51(185), 33992-34003.
17. U.S. EPA. (1996). Proposed guidelines for carcinogen risk assessment. Federal Register, 61(79), 17960-18011.
18. U.S. EPA. (1999). Science Advisory Board Review Draft, Guidelines for Carcinogen Risk Assessment (NCEA-F-0644). Washington, DC: EPA.
19. U.S. EPA. (1989). Risk Assessment Guidance for Superfund, Volume I Human Health Evaluation Manual, Part A Interim Final (EPA/540/1-89/002). Washington, DC: Office of Emergency and Remedial Response, U.S. EPA.
20. Faustman, E. M., & Omenn, G. S. (2001). Risk assessment. In C. D. Klaassen (Ed.), Toxicology, 6th ed. (pp. 83-104). New York: McGraw-Hill.
21. NRC. (1994). Science and Judgment in Risk Assessment. Washington, DC: National Academy Press.
22. GAO. (2001). Chemical Risk Assessment: Selected Federal Agencies' Procedures, Assumptions, and Policies (GAO-01-810). Washington, DC: U.S. General Accounting Office.
23. Rhomberg, L. R. (1997). A survey of methods for chemical health risk assessment among federal regulatory agencies. In Presidential/Congressional Commission on Risk Assessment and Risk Management (Ed.), Final Report. Washington, DC.
24. Swaney, J. A. (1997). The basic economics of risk analysis. In V. Molak (Ed.), Fundamentals of Risk Analysis and Risk Management (pp. 99-121). Boca Raton: CRC Press.
25. Johannesson, M., Pliskin, J. S., & Weinstein, M. C. (1993). Are healthy-years equivalents an improvement over quality-adjusted life years? Medical Decision Making, 13, 281-286.
26. Zerbe, R. O., & Dively, D. D. (1994). Benefit-Cost Analysis in Theory and Practice. New York: Harper Collins.
27. Tolley, G., Kenkel, D., & Fabian, R. (Eds.). (1994). Valuing Health for Policy: An Economic Approach. Chicago: University of Chicago Press.
28. Patrick, D. L., & Erickson, P. (1993). Health Status and Health Policy. New York: Oxford University Press.
29. Kenkel, D., Berger, M., & Blomquist, G. (1994). Contingent valuation of health. In G. Tolley, D. Kenkel, & R. Fabian (Eds.), Valuing Health for Policy (pp. 72-117). Chicago: University of Chicago Press.
30. Guillemin, F (1999). The value of utility: Assumptions underlying preferences and quality adjusted life years. Journal of Rheumatology, 26(9), 1861-1863.
31. Fabian, R. (1994). The QALY approach. In G. Tolley, D. Kenkel, & R. Fabian (Eds.), Valuing Health for Policy (pp. 118-136). Chicago: University of Chicago Press.
32. Nord, E., Pinto, J. L., Richardson, J., Menzel, P., & Ubel, P. (1999). Incorporating societal concerns for fairness in numerical valuations of health programmes. Health Economics, 8(1), 25-39.
33. Gerdtham, U. G., & Johannesson, M. (2000). Income-related inequality in life-years and quality-adjusted life-years. Journal of Health Economics, 19(6), 1007-26.
34. Tsevat, J. (2000). What do utilities measure? Medical Care, 38(9 Suppl), II160-II164.
35. Lenert, L., & Kaplan, R. M. (2000). Validity and interpretation of preference-based measures of health-related quality of life. Medical Care, 38(9 Suppl), II138-II150.
36. Murray, C., & Lopez, A. (1996). The Global Burden of Disease. Cambridge, MA: Harvard University Press.
37. Arnesen, T., & Nord, E. (1999). The value of DALY life: Problems with ethics and validity of disability adjusted life years. BMJ: British Medical Association, 319(7222), 1423-1425.
38. Sundby, J. (1999). Are women disfavoured in the estimation of disability adjusted life years and the global burden of disease? Scandinavian Journal of Public Health, 27(4), 279-285.
39. Ponce, R. A., Bartell, S. M., Wong, E. Y., LaFlamme, D., Carrington, C., Lee, R. C., Patrick, D. L., Faustman, E. M., & Bolger, M. (2000). Use of quality-adjusted life year weights with dose-response models for public health decisions: A case study of the risks and benefits of fish consumption. Risk Analysis, 20(4), 529-542.
40. Ponce, R. A., Wong, E. Y., & Faustman, E. M. (2001). Quality adjusted life years (QALYs) and dose-response models in environmental health policy analysis - Methodological considerations. Science of the Total Environment, 274(1-3), 79-91.
41. U.S. EPA. (1996). Mercury Study Report to Congress. Volume VI. Characterization of Human and Wildlife Risks from Anthropogenic Mercury Emissions in the United States. Cincinnati, OH: National Center for Environmental Assessment and Office of Air Quality Planning and Standards.
42. Marsh, D. O., Clarkson, T. W., Cox, C., Myers, G. J., Amin-Zaki, L., & Al-Tikriti, S. (1987). Fetal methylmercury poisoning. Relationship between concentration in single strands of maternal hair and child effects. Archives of Neurology, 44(10), 1017-1022.
43. Committee on Evaluation of the Safety of Fisheries Products. (1991). Seafood Safety. Washington, DC: National Academy Press.
44. Daviglus, M. L., Stamler, J., Orencia, A. J., Dyer, A. R., Liu, K., Greenland, P., Walsh, M. K., Morris, D., & Shekelle, R. B. (1997). Fish consumption and the 30-year risk of fatal myocardial infarction. New England Journal of Medicine, 336(15), 1046-1053.
45. Kind, P., Rosser, R., & Williams, A. (1982). Valuation of quality of life: Some psychometric evidence. In M. W. Jones-Lee (Ed.), The Value of Life and Safety (pp. 159-170). Amsterdam: North-Holland Publ. Co.
46. U.S. EPA. (1997). The Benefits and Costs of the Clean Air Act, 1970 to 1990 (EPA 410-R-97-001). Washington, DC: U.S. EPA, Office of Air and Radiation, Office of Policy, Planning and Evaluation.
47. U.S. EPA. (1999). The Benefits and Costs of the Clean Air Act 1990 to 2010 (EPA 410-R-97-002). Washington, DC: U.S. EPA, Office of Air and Radiation, Office of Policy, Planning and Evaluation.
48. Farrow, R. S., Wong, E., Ponce, R. A., Faustman, E. M., & Zerbe, R. O. (2001). Facilitating regulatory design and stake-holder participation - The FERET template with an application to the Clean Air Act. In P. S. Fischbeck & R. S. Farrow (Eds.), Improving Regulation. Washington, DC: Resources for the Future Press.